This funding, announced Friday by Moderna, builds on the $176 million it received from HHS last year to support earlier stages of vaccine research.

The support is designed to speed development of well-matched H5N1 vaccines and pave the way for vaccines against other ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu ...

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Yesterday the World Health Organization (WHO) said Tanzania has 1 confirmed case of Marburg and 25 suspected cases all from ...

A hearing on RFK Jr.'s appointment as HHS secretary has stalled; physicians protest his appointment and Trump has paused communications.

According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of ...

The Travelers Companies, Inc. TRV surged 5.7% to $252.79 after the company reported better-than-expected quarterly financial ...

CHELMSFORD, MA / ACCESSWIRE / December 10, 2024 / Harte Hanks, Inc. (NASDAQ:HHS), the 101-year-old Massachusetts-based global customer experience company, today announced it's collaborating with ...